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1、Background and purpose 
With the development of the society, the incidence of vascular disease shows the 
tendency of rising day by day. In many vascular diseases, they may be accompanied by the 
symptoms of limb ischemia, such as arteriosclerosis obliterans (ASO) , thrombosis angiitis 
obliterans(TAO). Surgical treatment mainly includes stent placement, angioplasty with 
balloon and synthetic vascular graft bypass surgery. However these methods have certain 
drawbacks, the vascular grafts indicated shortterm patency with thrombosis, the angioplasty 
and stent placement usually lead to re-narrowing after expanding the disordered lesion. For 
extensive vascular lesion unable to surgery or endovascular treatment, only by conservative 
medication, usually by vasodilator, anticoagulant, antiplatelet and other methods to improve 
the blood supply. With the development of the disease, drugs often cannot have very good 
effect, eventually leading to patients requiring amputation. Therefore, it is of great clinical 
significance to replace the occluded artery and restore the blood supply by regenerated the 
functional artery with collateral circulation in ischemic hindlimb . 
2、Materials and methods 
⑴Developing autologous tissue-engineered blood vessels (TEBV) in vitro, 
including preparing decellularized scaffold, isolating bone marrow mesenchymal stem 
cells (MSCs) and seeding MSCs onto the scaffold ; 
⑵ Preparing the materials which facilitate the formation of collateral blood 
vessel, including preparing VEGF-heparin controlled-releasing gelatin microspheres, 
collagen scaffold acting as the shelves for MSCs and VEGF- heparin microspheres  
⑶ Anastomosing one end of autologous TEBV to external iliac artery in 
ischemic model, the other end will be ligated, and wrapping the TEBV with collagen 
scaffold containing MSCs and VEGF- heparin microspheres;  
⑷Monitoring the patency of vascular graft and detecting the forming of 
functional artery with collateral circulation. 

















We have prepared the decellularized vascular scaffold with complete structure of 
extracellular matrix, good mechanical properties, low cytotoxicity and 
immunogenicity, then MSCs were planted on the scaffold, completed the construction 
of tissue-engineered blood vessels. At the same time the collagen scaffold with MSCs 
and VEGF- heparin controlled-releasing microspheres was prepared to promote 
angiogenesis. Finally, we successfully transplanted them into the ischemic hindlimb 
of the goats.  
Due to thrombosis, intimal hyperplasia and other reasons, partial occlusion 
occurred within two months after the tissue engineering blood vessel（TEBV） was 
transplanted into the body, however around the TEBV with large amount of collateral 
vessels formed. TEBV were partly occluded, but parts were patency and smooth inner 
wall. Histological and immunohistochemical analyses of the engineered vascular 
grafts demonstrated the partly existence of endothelium、smooth muscle infiltration 
and the presence of extracellular matrix components, such as collagen and elastin.  
 Developing a completely new functional artery with collateral vessels network which 
connect to the capillary and vena to improve blood supply  in ischemic hindlimb . This is a 
potential method of treatment for ischemic disease of  hindlimb.  
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似的组织工程血管[14]。Niklason 等将平滑肌细胞种植在 PGA 支架上，将其放在
模仿体内血管搏动的压力条件下培养 8 周，此法制备的组织工程血管表现出了
和天然血管相类似的生理特性和机械性能[15]。 



















细胞、软骨细胞以及脂肪细胞等。2003 年 Matsumura 等将骨髓间充质干细胞种
植在人工材料上，发现组织工程血管最终形成的血管壁细胞主要来源于种植的
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